I-131-IMAZA
131I-IMAZA is developed at the University of Wurzburg, Germany, together [...]
131I-IMAZA is developed at the University of Wurzburg, Germany, together [...]
131I-chTNT (Tumor Necrosis Therapy-1, Cotara®, Vivatuxin®, 131I-derlotuximab biotin - new [...]
131I-Iobenguane (131I-Metaiodobenzylguanidine, 131I-MIBG) is a generic radiopharmaceutical indicated for use [...]
131I-Sodium Iodide is the standard diagnostic and therapeutic agent for [...]
131I-81C6 (131I-Monoclonal Antibody 81C6, Neuradiab™) is a radioimmunoconjugate consisting of [...]
TLX101 (formerly ACD-101) is a small molecule (4-Iodophenylalanine), radioactively labeled [...]
131I-BA52 is a small molecule, a melanin-binding benzamide, being developed [...]
131I-TM601 (131I-Chlorotoxin) is a synthetic radiolabeled peptide with anti-angiogenic activity [...]
131I-Apamistamab (131I-BC8, Iomab-B™) is an anti-CD45 radioimmunotherapy for the [...]
131I-Iopofosine (131I-CLR-131, 131I-CLR-1404, 131I-NM404) is a small molecule, an alkyl [...]